Drug Profile
KRL 901
Alternative Names: KRL-901Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Krele Pharmaceuticals
- Developer Krele Pharmaceuticals Inc
- Class Drug withdrawal therapies
- Mechanism of Action Aldehyde dehydrogenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alcoholism
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Alcoholism in USA
- 26 Mar 2009 Clinical trials in Alcoholism in USA (unspecified route)